Tag: Hudson Institute of Medical Research
ASX biotech firm Noxopharm unveils anti-inflammatory skin disease drug
Australian biotech company Noxopharm Limited unveiled today its new preclinical product candidate from its Sofra technology platform that has shown effectiveness against inflammatory skin disease in preclinical models
ASX biotech firm Noxopharm’s new mRNA enhancer to make vaccines safer
Australian biotech company Noxopharm Limited unveiled today the development of a new mRNA vaccine enhancer that will make mRNA vaccines safer by reducing inflammation associated with mRNA vaccines.
Featured Article
Unlocking growth: Charting midsize manufacturers’ path with digital solutions
According to a recent study by Oxford Economics, midsized companies in the industrial manufacturing sector are setting their eyes on ambitious growth targets. The research, authored in partnership with SAP, revealed that 38% of industry leaders have identified market expansion as their top priority.
